The market isn't seeing SNTA's true potential. This stock is deeply undervalued at the moment. A true price range it should trade at would be $1.10 - $ 1.75 in the medium term even without any effects of expected positive news. SNTA's merger with Madrigal Pharma is also being discounted, while in actual fact it's a great combination, the management details...
IF Brexit happens, NZD is less affected as AUD is. Though there is an existing positive correlation between AUD & NZD, NZD will not fall as much as AUD. Carry trades prefer NZD Vehicle and with the robust economy with strong immigrant flow and a hot property sector will keep NZD up despite RBNZ's stance on a lower NZD.
